You are here

XORTX Therapeutics Inc.

XORTX Therapeutics Inc.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
XRX
CSE Index: 
Currency: 

XORTX Therapeutics Inc. is a biopharmaceutical company with three clinically advanced products in development – XRx-008 for Autosomal Dominant Polycystic Kidney Disease (ADPKD), XRx-101 for Coronavirus / COVID-19 infection in addition to ongoing in licensing activity relating to potential therapies for Type 2 Diabetic Nephropathy (T2DN). The Company has strong intellectual property rights and established proof of concept through independent clinical studies. XORTX is working to advance its clinical development stage products that target xanthine oxidase to inhibit production of uric acid. At XORTX Therapeutics, we are dedicated to developing medications to improve the quality of life and future of patients.

You are here

XORTX Therapeutics Inc. (XRX)

SEDAR Information

Company Info

Address
Suite 2400 - 745 Thurlow Street
Vancouver, BC V6E 0C5
Canada
Phone
(403) 607-2621
Email
adavidoff@xortx.com
Website
http://xortx.com
Listing date
Wednesday, September 30, 2015
Transfer Agent
TSX Trust Company
Auditor
Smythe LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
110,176,717
Reserved for Issuance: 
31,870,626
Total equity shares, as if converted: 
140,747,343

Company Officers

Allen Davidoff, President and Chief Executive Officer
Charlotte May, Corporate Secretary
W. Bruce Rowlands, Chairman
Paul J. Van Damme, Director
Ian Klassen, Director
Jacqueline Le Saux, Director
William Farley, Director
Amar Keshri, Chief Financial Officer
Dr. Stephen Haworth, Chief Medical Officer

Bulletins

10/01/2018

2018-0111 – Fundamental Change – APAC Resources Inc./XORTX Therapeutics Inc.

Le 10 janvier/January 2018

XORTX Therapeutics Inc., the issuer resulting from a Fundamental Change of APAC Resources Inc. has been approved for listing.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2021-09-14-Terry-Fox-Website.jpg

Terry Fox Virtual Run

Friday, September 17, 2021 to Sunday, September 19, 2021
Richard_Carleton_Website.png

Business of Cannabis: New York

Wednesday, September 29, 2021 -
9:00am to 7:00pm
2021-09-20-Digital-Securities-in-the-Capital-Markets_Website.jpg

Digital Securities in the Capital Markets

Wednesday, October 6, 2021 -
2:00pm to 4:00pm